The SCP Team

Richard L. Sherman
Mr. Sherman has been a Venture Partner with SCP focusing on the life sciences area.  Prior to joining SCP, he spent more than a decade (1976-1989) as Deputy General Counsel of SmithKline Beckman Corporation (now GlaxoSmithKline) and was founder and managing officer (1992-2001) of QED Technologies, Inc., a life science business consulting firm that is now a wholly-owned subsidiary of The Omnicom Group in New York.

Mr. Sherman has served on the Board of Directors of CytoMed, Inc., IBAH, Inc., Kenna Technologies, Inc., Mera Pharmaceuticals, Inc., and Sparta Pharmaceuticals.  He is Chairman of the Board of Biophage, Inc., and is a board member of the Sbarro Research Organization.  He also serves as Secretary and General Counsel of Hawaii Biotech, Inc., acts as a consultant to the law firm of Goodsill Anderson Quinn & Stifel, and is a
principal in CIP Capital, L.P.


He is on the Technology Advisory Board for The Children's Hospital of Philadelphia and is a member of the Advisory Board of the University of Hawaii Medical School.

Mr. Sherman graduated magna cum laude from the University of Nebraska (1968), where he was elected to Phi Beta Kappa.  He received his J.D. from New York University School of Law in 1971 as a Root-Tilden Scholar.

 

 


Home | Our Philosophy | Our Investment Strategy and Focus Areas | The Team
Our Portfolio | News | Contact Us | LP Login | Submit a Business Plan
© 2006 SCP Partners. All Rights Reserved.